President Biden, citing the need for maximum flexibility in the nation’s vaccination program, today announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

Johnson & Johnson is working with Merck to increase supply, making such a deal possible.

The purchase doubles the nation’s projected supply of Johnson & Johnson doses, to 200 million. The intent of the purchase is to prepare for long-term supply needs, including the eventual vaccination of children and the possible need for booster shots to protect against COVID-19 variants.

Related News Articles

Headline
The Food and Drug Administration today authorized a single Pfizer COVID-19 booster dose for children aged 5-11 who completed the Pfizer vaccine primary series…
Headline
A recent op-ed in the online publication STAT contains “blatant factual inaccuracies” and omits critical information about hospital and health systems’…
Blog
A recent op-ed in the online publication STAT (Turn off the spigot for hospitals’ COVID-19 relief funding) contains blatant factual inaccuracies but also omits…
Headline
The Health Resources and Services Administration has extended to May 18 the deadline for health care providers who received Provider Relief Fund payments…
Perspective
Yesterday, our country surpassed a grim and somber milestone: 1 million COVID-19 deaths in the U.S.. America’s hospitals and health systems — and their…
Headline
As U.S. COVID-19 deaths today surpassed 1 million, the AHA, American Medical Association, and American Nurses Association continued to urge everyone who is…